Position in JNJ
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$13,586,125
+$336,500 QoQ
Shares Held
53,495
-1.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.03%
of 13F equity value
Holder Rank
#936
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BURNS J W & CO INC/NY holds $40,501,690 across 10 Drug Manufacturers - General names. JNJ ranks #1 (33.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
53,495 | $13,586,125 | |
| 2 | ABBV |
AbbVie Inc.
|
36,406 | $9,161,205 | |
| 3 | AMGN |
Amgen Inc
|
22,691 | $8,216,864 | |
| 4 | LLY |
ELI LILLY & Co
|
4,335 | $5,199,529 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,774 | $1,542,717 | |
| 6 | MRK |
Merck & Co., Inc.
|
7,012 | $901,042 | |
| 7 | NVS |
Novartis AG
|
4,915 | $770,278 | |
| 8 | PFE |
Pfizer Inc
|
29,042 | $699,331 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,586,125 | 53,495 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $13,249,625 | 54,204 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $11,203,445 | 54,136 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $10,103,164 | 54,488 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $8,233,377 | 53,901 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $9,192,013 | 55,427 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $8,394,034 | 58,042 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $9,988,730 | 61,636 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $8,902,751 | 60,911 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $9,711,284 | 61,390 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $9,682,613 | 61,775 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $9,716,775 | 62,387 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $10,512,009 | 63,509 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $10,011,760 | 64,592 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $11,290,054 | 63,912 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $10,394,270 | 63,628 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $11,296,203 | 63,637 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $11,150,425 | 62,915 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $11,021,013 | 64,424 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $10,351,181 | 64,094 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $10,420,793 | 63,256 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $10,563,596 | 64,275 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $9,916,671 | 63,011 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $9,232,942 | 62,016 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $8,717,231 | 61,987 | Shares | Sole | 2020-07-06 | |
| 2020-03-31 | $8,081,673 | 61,631 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||